NASDAQ: ACLX
Arcellx Inc Stock Ownership - Who owns Arcellx?

Insider buying vs selling

Have Arcellx Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Kavita PatelDirector2025-06-101,500$67.36
$101.04kSell
Kavita PatelDirector2025-06-101,500$6.66
$9.99kBuy
Michelle GilsonCHIEF FINANCIAL OFFICER2025-05-278,449$64.38
$543.91kSell
Michelle GilsonCHIEF FINANCIAL OFFICER2025-05-273,786$63.62
$240.87kSell
Kavita PatelDirector2025-05-201,500$6.66
$9.99kBuy
Kavita PatelDirector2025-05-201,500$58.43
$87.65kSell
Kavita PatelDirector2025-04-291,500$64.20
$96.30kSell
Kavita PatelDirector2025-04-291,500$6.66
$9.99kBuy
Kavita PatelDirector2025-04-081,500$6.66
$9.99kBuy
Kavita PatelDirector2025-04-081,500$57.50
$86.25kSell

1 of 14

ACLX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ACLX insiders and whales buy or sell their stock.

ACLX Shareholders

What type of owners hold Arcellx Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Gilead Sciences Inc12.20%6,720,803$443.57MInsider
Gilead Sciences Inc12.20%6,720,803$443.57MInstitution
Sr One Capital Management LLC11.83%6,520,370$430.34MInsider
Jill Carroll11.51%6,340,738$418.49MInsider
Fmr LLC11.44%6,303,679$416.04MInstitution
Scott D. Sandell8.62%4,748,116$313.38MInsider
Peter W. Sonsini8.61%4,746,083$313.24MInsider
Mohamad Makhzoumi8.61%4,745,545$313.21MInsider
Forest Baskett8.61%4,745,262$313.19MInsider
Anthony A. Florence Jr.8.61%4,745,262$313.19MInsider

1 of 3

ACLX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ACLX50.58%49.42%Net SellingNet Selling
ACAD72.62%27.38%Net SellingNet Selling
CRSP65.79%34.21%Net SellingNet Selling
SRPT75.07%24.93%Net SellingNet Buying
RARE84.71%15.29%Net SellingNet Selling

Arcellx Stock Ownership FAQ

Who owns Arcellx?

Arcellx (NASDAQ: ACLX) is owned by 111.73% institutional shareholders, 109.18% Arcellx insiders, and 0.00% retail investors. Gilead Sciences Inc is the largest individual Arcellx shareholder, owning 6.72M shares representing 12.20% of the company. Gilead Sciences Inc's Arcellx shares are currently valued at $443.57M.

If you're new to stock investing, here's how to buy Arcellx stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.